25658940|t|Protection of TGF-beta1 against neuroinflammation and neurodegeneration in Abeta1-42-induced Alzheimer's disease model rats.
25658940|a|Neuroinflammation has been reported to be associated with Alzheimer's disease (AD) pathogenesis. Neuroinflammation is generally considered as an outcome of glial activation; however, we recently demonstrated that T helper (Th)17 cells, a subpopulation of proinflammatory CD4+ T cells, are also involved in AD pathogenesis. Transforming growth factor (TGF)-beta1, a cytokine that can be expressed in the brain, can be immunosuppressive, but its effects on lymphocyte-mediated neuroinflammation in AD pathogenesis have not been well addressed. In the current study we administered TGF-beta1 via intracerebroventricle (ICV) and intranasal (IN) routes in AD model rats to investigate its antiinflammatory and neuroprotective effects. The AD rat model was prepared by bilateral hippocampal injection of amyloid-beta (Abeta)1-42. TGF-beta1 was administered via ICV one hour prior to Abeta1-42 injection or via both nares seven days after Abeta1-42 injection. ICV administration of TGF-beta1 before Abeta1-42 injection remarkably ameliorated Abeta1-42-induced neurodegeneration and prevented Abeta1-42-induced increases in glia-derived proinflammatory mediators (TNF-alpha, IL-1beta and iNOS), as well as T cell-derived proinflammatory cytokines (IFN-gamma, IL-2, IL-17 and IL-22), in the hypothalamus, serum or cerebrospinal fluid (CSF) in a concentration-dependent manner. TGF-beta1 pretreatment also prevented Abeta1-42-induced decreases in the neurotrophic factors, IGF-1, GDNF and BDNF, and in the antiinflammatory cytokine, IL-10. Similarly, IN administration of TGF-beta1 after Abeta1-42 injection reduced neurodegeneration, elevation of proinflammatory mediators and cytokines, and reduction of neurotrophic and antiinflammatory factors, in the hypothalamus, serum or CSF. These findings suggest that TGF-beta1 suppresses glial and T cell-mediated neuroinflammation and thereby alleviates AD-related neurodegeneration. The effectiveness of IN administered TGF-beta1 in reducing Abeta1-42 neurotoxicity suggests a possible therapeutic approach in patients with AD. 
25658940	14	23	TGF-beta1	Gene	59086
25658940	32	49	neuroinflammation	Disease	MESH:D000090862
25658940	54	71	neurodegeneration	Disease	MESH:D019636
25658940	93	112	Alzheimer's disease	Disease	MESH:D000544
25658940	119	123	rats	Species	10116
25658940	125	142	Neuroinflammation	Disease	MESH:D000090862
25658940	183	202	Alzheimer's disease	Disease	MESH:D000544
25658940	204	206	AD	Disease	MESH:D000544
25658940	222	239	Neuroinflammation	Disease	MESH:D000090862
25658940	380	395	proinflammatory	Disease	
25658940	396	399	CD4	Gene	24932
25658940	431	433	AD	Disease	MESH:D000544
25658940	448	486	Transforming growth factor (TGF)-beta1	Gene	59086
25658940	600	617	neuroinflammation	Disease	MESH:D000090862
25658940	621	623	AD	Disease	MESH:D000544
25658940	704	713	TGF-beta1	Gene	59086
25658940	776	778	AD	Disease	MESH:D000544
25658940	785	789	rats	Species	10116
25658940	859	861	AD	Disease	MESH:D000544
25658940	862	865	rat	Species	10116
25658940	949	958	TGF-beta1	Gene	59086
25658940	1100	1109	TGF-beta1	Gene	59086
25658940	1178	1195	neurodegeneration	Disease	MESH:D019636
25658940	1254	1269	proinflammatory	Disease	
25658940	1281	1290	TNF-alpha	Gene	24835
25658940	1292	1300	IL-1beta	Gene	24494
25658940	1305	1309	iNOS	Gene	24599
25658940	1365	1374	IFN-gamma	Gene	25712
25658940	1376	1380	IL-2	Gene	116562
25658940	1382	1387	IL-17	Gene	301289
25658940	1392	1397	IL-22	Gene	500836
25658940	1493	1502	TGF-beta1	Gene	59086
25658940	1588	1593	IGF-1	Gene	24482
25658940	1595	1599	GDNF	Gene	25453
25658940	1604	1608	BDNF	Gene	24225
25658940	1648	1653	IL-10	Gene	25325
25658940	1687	1696	TGF-beta1	Gene	59086
25658940	1731	1748	neurodegeneration	Disease	MESH:D019636
25658940	1927	1936	TGF-beta1	Gene	59086
25658940	1974	1991	neuroinflammation	Disease	MESH:D000090862
25658940	2015	2017	AD	Disease	MESH:D000544
25658940	2026	2043	neurodegeneration	Disease	MESH:D019636
25658940	2082	2091	TGF-beta1	Gene	59086
25658940	2114	2127	neurotoxicity	Disease	MESH:D020258
25658940	2172	2180	patients	Species	9606
25658940	2186	2188	AD	Disease	MESH:D000544
25658940	Association	MESH:D000544	24932
25658940	Positive_Correlation	24482	59086
25658940	Positive_Correlation	25453	59086
25658940	Negative_Correlation	24494	59086
25658940	Negative_Correlation	MESH:D000090862	59086
25658940	Positive_Correlation	25325	59086
25658940	Negative_Correlation	MESH:D019636	59086
25658940	Positive_Correlation	24225	59086
25658940	Negative_Correlation	500836	59086
25658940	Negative_Correlation	24835	59086
25658940	Negative_Correlation	116562	59086
25658940	Negative_Correlation	301289	59086
25658940	Negative_Correlation	24599	59086
25658940	Negative_Correlation	25712	59086

